Posters & Presentations

Stay up to date with the latest clinical and evaluation data
Browse below for posters and presentations from recent conference appearances

ResistancePlus MGPlexPCR VHSPipeline Posters

A primary investigation of Mycoplasma genitalium coinfection with Chlamydia trachomatis in southern Denmark

Chen M et al ECCMID (Madrid) 2018

|

Specimens analysed in this study were collected and sent for CT/NG testing by general practitioners when a patient is suspected for sexually transmitted bacterial infections. 147 CT positive (5 of them are CT/NG positive) urinary samples were analysed with a new multiplex quantitative PCR assay, SpeeDx Resistance Plus MG 23S assay with Cobas® z480, which stimultaneously detects MG and 5 mutations at positions 2058 and 2059 in the 23S rRNA gene, to provide information on strains resistant to macrolide-based antibiotics.

Mycoplasma genitalium in asymptomatic people with sexual risk behaviours; screen or
not to screen, that’s the question

Fernández-Huerta M et al ECCMID (Madrid) 2018

|

During the study period, a total of 1404 specimens from 890 patients were tested for MG and macrolide resistance. The study was conducted prospectively, between October 2017 and January 2018, among asymptomatic users attending at Drassanes Exprés (Vall d´Hebron, Barcelona).

Mycoplasma genitalium in Scotland 2018

Kate Templeton BASHH (Edinburgh) 2018

|

The aim of the study is to determine the frequency of Mycoplasma genitalium presence and its resistance to macrolides within the NHS Lothian and NHS GGC sexual health services.

Mycoplasma genitalium: macrolide resistance among a 2016-2017 cohort of patients in Barcelona, Spain.